Helicoverpa zea isolate HzStark_Cry1AcR chromosome 26, ilHelZeax1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Noctuoidea; Noctuidae; Heliothinae; Helicoverpa.
REFSEQ INFORMATION: The reference sequence is identical to\nCM040228.1.\nAssembly name: ilHelZeax1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the United States Department of\nAgriculture on 2022/03/18. The original whole-genome shotgun\nproject has the accession JAKYJW000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: United States Department of Agriculture\nAssembly Date :: 31-DEC-2021\nAssembly Method :: FALCON v. 1.8.1; FALCON-Unzip v. 1.3.7;\n purge_dups v. 1.2.5; bwa-mem v. 2.2.1;\n Juicebox v. 1.11.08; Arrow gcpp v. 2.0.2;\n FreeBayes v. 1.0.2; Merqury v. 1.1\nAssembly Name :: ilHelZeax1.1\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 144x\nSequencing Technology :: PacBio Sequel II CLR; Illumina NovaSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Helicoverpa zea Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
laboratory colony at USDA ARS Southern Insect Management Unit, Stoneville, MS
USDA-ARS Genetics and Sustainability Agricultural Research Unit, Starkville, MS, USA
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 72% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124643134
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger protein OZF-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger protein OZF-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gastrula zinc finger protein XlCGF57.1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
gastrula zinc finger protein XlCGF26.1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
dynamin-like 120 kDa protein, mitochondrial, transcript variant X5
dynamin-like 120 kDa protein, mitochondrial, transcript variant X4
dynamin-like 120 kDa protein, mitochondrial, transcript variant X3
dynamin-like 120 kDa protein, mitochondrial, transcript variant X2
dynamin-like 120 kDa protein, mitochondrial, transcript variant X1
dynamin-like 120 kDa protein, mitochondrial isoform X4
dynamin-like 120 kDa protein, mitochondrial isoform X3
dynamin-like 120 kDa protein, mitochondrial isoform X2
dynamin-like 120 kDa protein, mitochondrial isoform X1
dynamin-like 120 kDa protein, mitochondrial isoform X5
thyroid receptor-interacting protein 11-like, transcript variant X1
thyroid receptor-interacting protein 11-like isoform X1
thyroid receptor-interacting protein 11-like, transcript variant X2
thyroid receptor-interacting protein 11-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
EH domain-binding protein 1, transcript variant X1
EH domain-binding protein 1, transcript variant X2
zinc finger protein 62-like, transcript variant X1
zinc finger protein 62-like, transcript variant X2
uncharacterized protein LOC124642991 isoform X1
zinc finger protein 11-like, transcript variant X1
zinc finger protein 11-like, transcript variant X3
zinc finger protein 11-like, transcript variant X2
zinc finger protein 43-like, transcript variant X1
zinc finger protein 43-like, transcript variant X3
zinc finger protein 43-like, transcript variant X2
zinc finger protein 708-like, transcript variant X2
zinc finger protein 708-like, transcript variant X1
neural/ectodermal development factor IMP-L2-like, transcript variant X1
neural/ectodermal development factor IMP-L2-like, transcript variant X2
neural/ectodermal development factor IMP-L2-like isoform X2
neural/ectodermal development factor IMP-L2-like isoform X1
neural/ectodermal development factor IMP-L2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
neural/ectodermal development factor IMP-L2-like
damage-control phosphatase ARMT1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
damage-control phosphatase ARMT1-like, transcript variant X1
damage-control phosphatase ARMT1-like isoform X2
damage-control phosphatase ARMT1-like isoform X1
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
uncharacterized LOC124642997, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC124642997, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized protein LOC124642997 isoform X1
uncharacterized protein LOC124642997 isoform X2
zinc finger protein 12-like, transcript variant X2
zinc finger protein 12-like, transcript variant X1
GATA zinc finger domain-containing protein 14-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 75% coverage of the annotated genomic feature by RNAseq alignments
probable serine/threonine-protein kinase clkA
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
proton-coupled amino acid transporter 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
proton-coupled amino acid transporter-like protein pathetic, transcript variant X1
proton-coupled amino acid transporter-like protein pathetic isoform X1
proton-coupled amino acid transporter-like protein pathetic, transcript variant X2
proton-coupled amino acid transporter-like protein pathetic isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
zinc finger matrin-type protein 5, transcript variant X2
zinc finger matrin-type protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124643013, transcript variant X1
uncharacterized LOC124643013, transcript variant X2
uncharacterized protein LOC124643013 isoform X1
uncharacterized protein LOC124643013 isoform X2
ryanodine receptor, transcript variant X1
ryanodine receptor, transcript variant X10
ryanodine receptor, transcript variant X4
ryanodine receptor, transcript variant X13
ryanodine receptor, transcript variant X2
ryanodine receptor, transcript variant X6
ryanodine receptor, transcript variant X14
ryanodine receptor, transcript variant X7
ryanodine receptor, transcript variant X11
ryanodine receptor, transcript variant X3
ryanodine receptor, transcript variant X25
ryanodine receptor, transcript variant X16
ryanodine receptor, transcript variant X17
ryanodine receptor, transcript variant X19
ryanodine receptor, transcript variant X18
ryanodine receptor, transcript variant X12
ryanodine receptor, transcript variant X15
ryanodine receptor, transcript variant X20
ryanodine receptor, transcript variant X5
ryanodine receptor, transcript variant X23
ryanodine receptor, transcript variant X24
ryanodine receptor, transcript variant X9
ryanodine receptor, transcript variant X8
ryanodine receptor, transcript variant X21
ryanodine receptor, transcript variant X22
ryanodine receptor, transcript variant X26
3-oxoacyl-[acyl-carrier-protein] reductase FabG-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 76% coverage of the annotated genomic feature by RNAseq alignments
glycerol kinase-like, transcript variant X3
glycerol kinase-like, transcript variant X4
glycerol kinase-like, transcript variant X1
glycerol kinase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 73% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
chromatin modification-related protein eaf-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chromatin modification-related protein eaf-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chromatin modification-related protein eaf-1-like isoform X2
chromatin modification-related protein eaf-1-like isoform X1
prostamide/prostaglandin F synthase-like, transcript variant X4
prostamide/prostaglandin F synthase-like, transcript variant X1
prostamide/prostaglandin F synthase-like, transcript variant X2
prostamide/prostaglandin F synthase-like, transcript variant X3
prostamide/prostaglandin F synthase-like isoform X4
prostamide/prostaglandin F synthase-like isoform X1
prostamide/prostaglandin F synthase-like isoform X3
prostamide/prostaglandin F synthase-like isoform X2
serine/threonine-protein kinase Genghis Khan, transcript variant X5
serine/threonine-protein kinase Genghis Khan, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein kinase Genghis Khan, transcript variant X2
serine/threonine-protein kinase Genghis Khan, transcript variant X3
serine/threonine-protein kinase Genghis Khan, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein kinase Genghis Khan isoform X5
serine/threonine-protein kinase Genghis Khan isoform X1
serine/threonine-protein kinase Genghis Khan isoform X2
serine/threonine-protein kinase Genghis Khan isoform X3
serine/threonine-protein kinase Genghis Khan isoform X4
uncharacterized LOC124643091, transcript variant X1
uncharacterized LOC124643091, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein LOC124643091 isoform X1
uncharacterized protein LOC124643091 isoform X3
uncharacterized LOC124643091, transcript variant X2
uncharacterized protein LOC124643091 isoform X2
uncharacterized LOC124643093, transcript variant X3
uncharacterized LOC124643093, transcript variant X1
uncharacterized LOC124643093, transcript variant X2
uncharacterized protein LOC124643093 isoform X1
uncharacterized protein LOC124643093 isoform X2
thioredoxin-related transmembrane protein 1-like
homeobox protein OTX1-like, transcript variant X2
homeobox protein OTX1-like, transcript variant X1
lysophosphatidylserine lipase ABHD12-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
pleckstrin homology-like domain family B member 2, transcript variant X1
pleckstrin homology-like domain family B member 2, transcript variant X2
uncharacterized protein LOC124642968 isoform X1
pleckstrin homology-like domain family B member 2, transcript variant X3
pleckstrin homology-like domain family B member 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
serine palmitoyltransferase small subunit A
m7GpppX diphosphatase, transcript variant X1
m7GpppX diphosphatase, transcript variant X2
uncharacterized protein LOC124643006 isoform X2
sprouty-related, EVH1 domain-containing protein 2
delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
GTP cyclohydrolase 1, transcript variant X2
GTP cyclohydrolase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transfer RNA proline (anticodon AGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 26-like, transcript variant X2
zinc finger protein 26-like, transcript variant X1
adrenodoxin-like protein 1, mitochondrial, transcript variant X2
adrenodoxin-like protein 1, mitochondrial isoform X2
adrenodoxin-like protein 1, mitochondrial, transcript variant X1
adrenodoxin-like protein 1, mitochondrial isoform X1
heterogeneous nuclear ribonucleoprotein L-like, transcript variant X1
heterogeneous nuclear ribonucleoprotein L-like, transcript variant X2
heterogeneous nuclear ribonucleoprotein L-like, transcript variant X3
heterogeneous nuclear ribonucleoprotein L-like, transcript variant X4
heterogeneous nuclear ribonucleoprotein L-like, transcript variant X5
heterogeneous nuclear ribonucleoprotein L-like isoform X1
heterogeneous nuclear ribonucleoprotein L-like isoform X2
heterogeneous nuclear ribonucleoprotein L-like isoform X3
heterogeneous nuclear ribonucleoprotein L-like isoform X4
heterogeneous nuclear ribonucleoprotein L-like isoform X5
uncharacterized oxidoreductase SSP0419-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 81% coverage of the annotated genomic feature by RNAseq alignments
irregular chiasm C-roughest protein-like
irregular chiasm C-roughest protein-like, transcript variant X2
irregular chiasm C-roughest protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
irregular chiasm C-roughest protein-like isoform X2
irregular chiasm C-roughest protein-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 10% coverage of the annotated genomic feature by RNAseq alignments
irregular chiasm C-roughest protein-like, transcript variant X3
irregular chiasm C-roughest protein-like, transcript variant X4
irregular chiasm C-roughest protein-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC124643000, transcript variant X2
uncharacterized LOC124643000, transcript variant X1
E3 ubiquitin-protein ligase CBL, transcript variant X1
E3 ubiquitin-protein ligase CBL, transcript variant X2
E3 ubiquitin-protein ligase CBL, transcript variant X3
E3 ubiquitin-protein ligase CBL-B-B isoform X1
E3 ubiquitin-protein ligase CBL-B-B isoform X2
E3 ubiquitin-protein ligase CBL isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 32% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 3% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 13% coverage of the annotated genomic feature by RNAseq alignments
neutral alpha-glucosidase AB, transcript variant X2
neutral alpha-glucosidase AB, transcript variant X1
macro domain-containing protein CT2219-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
zinc finger protein 436-like, transcript variant X2
zinc finger protein 436-like, transcript variant X1
uncharacterized LOC124642863, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC124642863, transcript variant X2
uncharacterized protein LOC124642863 isoform X2
uncharacterized protein LOC124642863 isoform X1
valine--tRNA ligase-like, transcript variant X2
valine--tRNA ligase-like, transcript variant X1
leucine-rich repeat-containing protein 10, transcript variant X1
leucine-rich repeat-containing protein 10, transcript variant X2
leucine-rich repeat-containing protein 10 isoform X2
leucine-rich repeat-containing protein 10 isoform X1
cofilin/actin-depolymerizing factor homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124642901, transcript variant X2
uncharacterized LOC124642901, transcript variant X1
uncharacterized protein LOC124642901 isoform X1
uncharacterized protein LOC124642901 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
60S ribosome subunit biogenesis protein NIP7 homolog
uncharacterized LOC124643050, transcript variant X1
uncharacterized LOC124643050, transcript variant X2
uncharacterized protein LOC124643050 isoform X1
uncharacterized protein LOC124643050 isoform X2
heterogeneous nuclear ribonucleoprotein U-like protein 1, transcript variant X1
heterogeneous nuclear ribonucleoprotein U-like protein 1, transcript variant X2
heterogeneous nuclear ribonucleoprotein U-like protein 1 isoform X1
heterogeneous nuclear ribonucleoprotein U-like protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
serine/threonine-protein kinase MARK2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase MARK2-like, transcript variant X2
serine/threonine-protein kinase MARK2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine-protein kinase MARK2-like, transcript variant X5
serine/threonine-protein kinase MARK2-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein kinase MARK2-like, transcript variant X1
serine/threonine-protein kinase MARK2-like, transcript variant X17
serine/threonine-protein kinase MARK2-like, transcript variant X16
serine/threonine-protein kinase MARK2-like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine-protein kinase MARK2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine-protein kinase MARK2-like, transcript variant X6
serine/threonine-protein kinase MARK2-like, transcript variant X12
serine/threonine-protein kinase MARK2-like, transcript variant X10
serine/threonine-protein kinase MARK2-like, transcript variant X9
serine/threonine-protein kinase MARK2-like, transcript variant X8
serine/threonine-protein kinase MARK2-like, transcript variant X11
serine/threonine-protein kinase MARK2-like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
serine/threonine-protein kinase MARK2-like, transcript variant X19
serine/threonine-protein kinase MARK2-like, transcript variant X20
serine/threonine-protein kinase MARK2-like, transcript variant X21
serine/threonine-protein kinase MARK2-like, transcript variant X22
MAP/microtubule affinity-regulating kinase 3-like isoform X17
MAP/microtubule affinity-regulating kinase 3-like isoform X16
MAP/microtubule affinity-regulating kinase 3-like isoform X14
serine/threonine-protein kinase MARK2-like isoform X12
serine/threonine-protein kinase MARK2-like isoform X9
MAP/microtubule affinity-regulating kinase 3-like isoform X5
MAP/microtubule affinity-regulating kinase 3-like isoform X4
serine/threonine-protein kinase MARK2-like isoform X10
serine/threonine-protein kinase MARK2-like isoform X8
serine/threonine-protein kinase MARK2-like isoform X7
serine/threonine-protein kinase MARK2-like isoform X2
serine/threonine-protein kinase MARK2-like isoform X3
MAP/microtubule affinity-regulating kinase 3-like isoform X13
serine/threonine-protein kinase MARK2-like isoform X11
serine/threonine-protein kinase MARK2-like isoform X6
MAP/microtubule affinity-regulating kinase 3-like isoform X1
MAP/microtubule affinity-regulating kinase 3-like isoform X19
MAP/microtubule affinity-regulating kinase 3-like isoform X18
serine/threonine-protein kinase MARK2-like, transcript variant X18
serine/threonine-protein kinase MARK2-like isoform X15
poly(A) polymerase type 3, transcript variant X1
poly(A) polymerase type 3, transcript variant X5
poly(A) polymerase type 3, transcript variant X3
poly(A) polymerase type 3, transcript variant X6
poly(A) polymerase type 3, transcript variant X8
poly(A) polymerase type 3, transcript variant X2
poly(A) polymerase type 3, transcript variant X7
poly(A) polymerase type 3, transcript variant X4
zinc finger protein 674-like, transcript variant X1
zinc finger protein 674-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
zinc finger protein 184-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
zinc finger protein 184-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124643034, transcript variant X2
uncharacterized LOC124643034, transcript variant X1
uncharacterized LOC124643034, transcript variant X3
uncharacterized LOC124642952, transcript variant X1
uncharacterized protein LOC124642952 isoform X1
uncharacterized LOC124642952, transcript variant X2
uncharacterized protein LOC124642952 isoform X2
cilia- and flagella-associated protein 251-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 41% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 47% coverage of the annotated genomic feature by RNAseq alignments
serologically defined colon cancer antigen 8 homolog, transcript variant X2
serologically defined colon cancer antigen 8 homolog, transcript variant X7
serologically defined colon cancer antigen 8 homolog, transcript variant X1
serologically defined colon cancer antigen 8 homolog isoform X2
serologically defined colon cancer antigen 8 homolog isoform X1
serologically defined colon cancer antigen 8 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serologically defined colon cancer antigen 8 homolog isoform X6
serologically defined colon cancer antigen 8 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serologically defined colon cancer antigen 8 homolog isoform X4
serologically defined colon cancer antigen 8 homolog, transcript variant X3
serologically defined colon cancer antigen 8 homolog isoform X3
serologically defined colon cancer antigen 8 homolog, transcript variant X5
serologically defined colon cancer antigen 8 homolog isoform X5
mitochondrial import receptor subunit TOM20 homolog
vacuolar protein sorting-associated protein 26B-like
mitochondrial import inner membrane translocase subunit Tim10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
deubiquitinase DESI2, transcript variant X3
deubiquitinase DESI2, transcript variant X2
deubiquitinase DESI2, transcript variant X1
deubiquitinase DESI2, transcript variant X5
deubiquitinase DESI2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
lactoylglutathione lyase, transcript variant X1
lactoylglutathione lyase, transcript variant X2
lactoylglutathione lyase, transcript variant X3
uncharacterized LOC124643140, transcript variant X1
uncharacterized LOC124643140, transcript variant X2
uncharacterized protein LOC124643140 isoform X2
uncharacterized protein LOC124643140 isoform X1
nose resistant to fluoxetine protein 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 15% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein K02A2.6-like, transcript variant X1
uncharacterized protein K02A2.6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized protein K02A2.6-like isoform X1
uncharacterized protein LOC124643030 isoform X2
transcription factor MafK, transcript variant X1
transcription factor MafK, transcript variant X2
RNA polymerase-associated protein Rtf1, transcript variant X1
RNA polymerase-associated protein Rtf1, transcript variant X2
RNA polymerase-associated protein Rtf1 isoform X1
RNA polymerase-associated protein Rtf1 isoform X2
homeobox protein 9-like, transcript variant X1
homeobox protein 9-like, transcript variant X2
uncharacterized LOC124643114, transcript variant X3
uncharacterized LOC124643114, transcript variant X2
uncharacterized LOC124643114, transcript variant X1
homeobox protein six1a-like, transcript variant X3
homeobox protein six1a-like, transcript variant X2
homeobox protein six1a-like, transcript variant X1
regulator of chromosome condensation, transcript variant X2
regulator of chromosome condensation, transcript variant X4
regulator of chromosome condensation, transcript variant X1
regulator of chromosome condensation, transcript variant X3
regulator of chromosome condensation isoform X1
regulator of chromosome condensation isoform X2
uncharacterized LOC124643073, transcript variant X1
uncharacterized protein LOC124643073 isoform X1
uncharacterized LOC124643073, transcript variant X2
uncharacterized protein LOC124643073 isoform X2
uncharacterized LOC124642939, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC124642939, transcript variant X3
uncharacterized LOC124642939, transcript variant X1
uncharacterized LOC124642939, transcript variant X2
uncharacterized protein LOC124642939 isoform X1
uncharacterized protein LOC124642939 isoform X2
uncharacterized protein LOC124642939 isoform X3
ALK tyrosine kinase receptor, transcript variant X2
ALK tyrosine kinase receptor, transcript variant X1
ALK tyrosine kinase receptor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phospholipid transfer protein C2CD2L, transcript variant X2
phospholipid transfer protein C2CD2L, transcript variant X19
phospholipid transfer protein C2CD2L, transcript variant X14
phospholipid transfer protein C2CD2L, transcript variant X3
phospholipid transfer protein C2CD2L, transcript variant X20
phospholipid transfer protein C2CD2L, transcript variant X4
phospholipid transfer protein C2CD2L, transcript variant X1
phospholipid transfer protein C2CD2L, transcript variant X5
phospholipid transfer protein C2CD2L, transcript variant X18
phospholipid transfer protein C2CD2L, transcript variant X17
phospholipid transfer protein C2CD2L, transcript variant X16
phospholipid transfer protein C2CD2L, transcript variant X15
phospholipid transfer protein C2CD2L, transcript variant X10
phospholipid transfer protein C2CD2L, transcript variant X11
phospholipid transfer protein C2CD2L, transcript variant X13
phospholipid transfer protein C2CD2L, transcript variant X12
phospholipid transfer protein C2CD2L, transcript variant X6
phospholipid transfer protein C2CD2L, transcript variant X7
phospholipid transfer protein C2CD2L, transcript variant X9
phospholipid transfer protein C2CD2L, transcript variant X8
C2 domain-containing protein 2 isoform X8
uncharacterized protein LOC124642962 isoform X7
uncharacterized protein LOC124642962 isoform X6
C2 domain-containing protein 2 isoform X5
uncharacterized protein LOC124642962 isoform X2
uncharacterized protein LOC124642962 isoform X3
uncharacterized protein LOC124642962 isoform X1
uncharacterized protein LOC124642962 isoform X9
phospholipid transfer protein C2CD2L isoform X10
uncharacterized protein LOC124642962 isoform X4
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized protein K02A2.6-like, transcript variant X4
uncharacterized protein K02A2.6-like isoform X2
uncharacterized protein LOC124642961 isoform X4
uncharacterized protein K02A2.6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein K02A2.6-like isoform X3
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X7
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X6
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X5
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X4
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X2
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X3
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X1
mitogen-activated protein kinase kinase kinase kinase 5 isoform X7
mitogen-activated protein kinase kinase kinase kinase 5 isoform X6
mitogen-activated protein kinase kinase kinase kinase 5 isoform X5
mitogen-activated protein kinase kinase kinase kinase 5 isoform X4
mitogen-activated protein kinase kinase kinase kinase 5 isoform X2
mitogen-activated protein kinase kinase kinase kinase 5 isoform X3
mitogen-activated protein kinase kinase kinase kinase 5 isoform X1
ribosomal protein S6 kinase alpha-5-like, transcript variant X1
ribosomal protein S6 kinase alpha-5-like, transcript variant X4
ribosomal protein S6 kinase alpha-5-like, transcript variant X3
ribosomal protein S6 kinase alpha-5-like, transcript variant X2
ribosomal protein S6 kinase alpha-5-like isoform X1
ribosomal protein S6 kinase alpha-5-like isoform X3
ribosomal protein S6 kinase alpha-5-like isoform X2
ribosomal protein S6 kinase alpha-5-like isoform X4
actin-related protein 2, transcript variant X1
actin-related protein 2, transcript variant X2
probable ATP-dependent RNA helicase DHX35
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC124642905 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124643145, transcript variant X1
uncharacterized LOC124643145, transcript variant X2
uncharacterized protein LOC124643145 isoform X1
uncharacterized protein LOC124643145 isoform X2
RNA-binding protein 25-like, transcript variant X1
RNA-binding protein 25-like, transcript variant X2
uncharacterized LOC124643070, transcript variant X3
uncharacterized LOC124643070, transcript variant X2
uncharacterized LOC124643070, transcript variant X1
uncharacterized protein LOC124643070 isoform X3
uncharacterized protein LOC124643070 isoform X2
uncharacterized protein LOC124643070 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments